Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Asset Utilization Ratio (2019 - 2025)

Serina Therapeutics' Asset Utilization Ratio history spans 6 years, with the latest figure at 0.29 for Q2 2024.

  • For Q2 2024, Asset Utilization Ratio rose 6657.75% year-over-year to 0.29; the TTM value through Jun 2024 reached 0.29, up 6657.75%, while the annual FY2024 figure was 0.01, 98.62% down from the prior year.
  • Asset Utilization Ratio for Q2 2024 was 0.29 at Serina Therapeutics, down from 0.32 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.32 in Q1 2024 and bottomed at 0.36 in Q3 2021.
  • The 5-year median for Asset Utilization Ratio is 0.02 (2022), against an average of 0.05.
  • The largest annual shift saw Asset Utilization Ratio crashed 242.38% in 2021 before it skyrocketed 6657.75% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.11 in 2020, then surged by 148.77% to 0.05 in 2021, then tumbled by 74.9% to 0.01 in 2022, then soared by 2198.46% to 0.3 in 2023, then decreased by 1.2% to 0.29 in 2024.
  • Per Business Quant, the three most recent readings for SER's Asset Utilization Ratio are 0.29 (Q2 2024), 0.32 (Q1 2024), and 0.3 (Q4 2023).